13
|
Patterson N, Hattangadi N, Lane B, Lohmueller KE, Hafler DA, Oksenberg JR, Hauser SL, Smith MW, O’Brien SJ, Altshuler D, Daly MJ, Reich D. Methods for high-density admixture mapping of disease genes. Am J Hum Genet 2004; 74:979-1000. [PMID: 15088269 PMCID: PMC1181990 DOI: 10.1086/420871] [Citation(s) in RCA: 369] [Impact Index Per Article: 18.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2004] [Accepted: 03/03/2004] [Indexed: 01/12/2023] Open
Abstract
Admixture mapping (also known as "mapping by admixture linkage disequilibrium," or MALD) has been proposed as an efficient approach to localizing disease-causing variants that differ in frequency (because of either drift or selection) between two historically separated populations. Near a disease gene, patient populations descended from the recent mixing of two or more ethnic groups should have an increased probability of inheriting the alleles derived from the ethnic group that carries more disease-susceptibility alleles. The central attraction of admixture mapping is that, since gene flow has occurred recently in modern populations (e.g., in African and Hispanic Americans in the past 20 generations), it is expected that admixture-generated linkage disequilibrium should extend for many centimorgans. High-resolution marker sets are now becoming available to test this approach, but progress will require (a). computational methods to infer ancestral origin at each point in the genome and (b). empirical characterization of the general properties of linkage disequilibrium due to admixture. Here we describe statistical methods to estimate the ancestral origin of a locus on the basis of the composite genotypes of linked markers, and we show that this approach accurately estimates states of ancestral origin along the genome. We apply this approach to show that strong admixture linkage disequilibrium extends, on average, for 17 cM in African Americans. Finally, we present power calculations under varying models of disease risk, sample size, and proportions of ancestry. Studying approximately 2500 markers in approximately 2500 patients should provide power to detect many regions contributing to common disease. A particularly important result is that the power of an admixture mapping study to detect a locus will be nearly the same for a wide range of mixture scenarios: the mixture proportion should be 10%-90% from both ancestral populations.
Collapse
Affiliation(s)
- Nick Patterson
- Program in Medical and Population Genetics, Broad Institute, and Whitehead Institute for Biomedical Research, Cambridge, MA; Department of Genetics and Laboratory of Molecular Immunology, Harvard Medical School, Departments of Medicine and Molecular Biology, Massachusetts General Hospital, and Center for Neurologic Disease, Brigham and Women's Hospital, Boston; Georgetown University, Washington, DC; Department of Neurology, University of California at San Francisco, San Francisco; and Laboratory of Genomic Diversity, National Cancer Institute, and Basic Research Program, Science Applications International Corporation, Frederick, MD
| | - Neil Hattangadi
- Program in Medical and Population Genetics, Broad Institute, and Whitehead Institute for Biomedical Research, Cambridge, MA; Department of Genetics and Laboratory of Molecular Immunology, Harvard Medical School, Departments of Medicine and Molecular Biology, Massachusetts General Hospital, and Center for Neurologic Disease, Brigham and Women's Hospital, Boston; Georgetown University, Washington, DC; Department of Neurology, University of California at San Francisco, San Francisco; and Laboratory of Genomic Diversity, National Cancer Institute, and Basic Research Program, Science Applications International Corporation, Frederick, MD
| | - Barton Lane
- Program in Medical and Population Genetics, Broad Institute, and Whitehead Institute for Biomedical Research, Cambridge, MA; Department of Genetics and Laboratory of Molecular Immunology, Harvard Medical School, Departments of Medicine and Molecular Biology, Massachusetts General Hospital, and Center for Neurologic Disease, Brigham and Women's Hospital, Boston; Georgetown University, Washington, DC; Department of Neurology, University of California at San Francisco, San Francisco; and Laboratory of Genomic Diversity, National Cancer Institute, and Basic Research Program, Science Applications International Corporation, Frederick, MD
| | - Kirk E. Lohmueller
- Program in Medical and Population Genetics, Broad Institute, and Whitehead Institute for Biomedical Research, Cambridge, MA; Department of Genetics and Laboratory of Molecular Immunology, Harvard Medical School, Departments of Medicine and Molecular Biology, Massachusetts General Hospital, and Center for Neurologic Disease, Brigham and Women's Hospital, Boston; Georgetown University, Washington, DC; Department of Neurology, University of California at San Francisco, San Francisco; and Laboratory of Genomic Diversity, National Cancer Institute, and Basic Research Program, Science Applications International Corporation, Frederick, MD
| | - David A. Hafler
- Program in Medical and Population Genetics, Broad Institute, and Whitehead Institute for Biomedical Research, Cambridge, MA; Department of Genetics and Laboratory of Molecular Immunology, Harvard Medical School, Departments of Medicine and Molecular Biology, Massachusetts General Hospital, and Center for Neurologic Disease, Brigham and Women's Hospital, Boston; Georgetown University, Washington, DC; Department of Neurology, University of California at San Francisco, San Francisco; and Laboratory of Genomic Diversity, National Cancer Institute, and Basic Research Program, Science Applications International Corporation, Frederick, MD
| | - Jorge R. Oksenberg
- Program in Medical and Population Genetics, Broad Institute, and Whitehead Institute for Biomedical Research, Cambridge, MA; Department of Genetics and Laboratory of Molecular Immunology, Harvard Medical School, Departments of Medicine and Molecular Biology, Massachusetts General Hospital, and Center for Neurologic Disease, Brigham and Women's Hospital, Boston; Georgetown University, Washington, DC; Department of Neurology, University of California at San Francisco, San Francisco; and Laboratory of Genomic Diversity, National Cancer Institute, and Basic Research Program, Science Applications International Corporation, Frederick, MD
| | - Stephen L. Hauser
- Program in Medical and Population Genetics, Broad Institute, and Whitehead Institute for Biomedical Research, Cambridge, MA; Department of Genetics and Laboratory of Molecular Immunology, Harvard Medical School, Departments of Medicine and Molecular Biology, Massachusetts General Hospital, and Center for Neurologic Disease, Brigham and Women's Hospital, Boston; Georgetown University, Washington, DC; Department of Neurology, University of California at San Francisco, San Francisco; and Laboratory of Genomic Diversity, National Cancer Institute, and Basic Research Program, Science Applications International Corporation, Frederick, MD
| | - Michael W. Smith
- Program in Medical and Population Genetics, Broad Institute, and Whitehead Institute for Biomedical Research, Cambridge, MA; Department of Genetics and Laboratory of Molecular Immunology, Harvard Medical School, Departments of Medicine and Molecular Biology, Massachusetts General Hospital, and Center for Neurologic Disease, Brigham and Women's Hospital, Boston; Georgetown University, Washington, DC; Department of Neurology, University of California at San Francisco, San Francisco; and Laboratory of Genomic Diversity, National Cancer Institute, and Basic Research Program, Science Applications International Corporation, Frederick, MD
| | - Stephen J. O’Brien
- Program in Medical and Population Genetics, Broad Institute, and Whitehead Institute for Biomedical Research, Cambridge, MA; Department of Genetics and Laboratory of Molecular Immunology, Harvard Medical School, Departments of Medicine and Molecular Biology, Massachusetts General Hospital, and Center for Neurologic Disease, Brigham and Women's Hospital, Boston; Georgetown University, Washington, DC; Department of Neurology, University of California at San Francisco, San Francisco; and Laboratory of Genomic Diversity, National Cancer Institute, and Basic Research Program, Science Applications International Corporation, Frederick, MD
| | - David Altshuler
- Program in Medical and Population Genetics, Broad Institute, and Whitehead Institute for Biomedical Research, Cambridge, MA; Department of Genetics and Laboratory of Molecular Immunology, Harvard Medical School, Departments of Medicine and Molecular Biology, Massachusetts General Hospital, and Center for Neurologic Disease, Brigham and Women's Hospital, Boston; Georgetown University, Washington, DC; Department of Neurology, University of California at San Francisco, San Francisco; and Laboratory of Genomic Diversity, National Cancer Institute, and Basic Research Program, Science Applications International Corporation, Frederick, MD
| | - Mark J. Daly
- Program in Medical and Population Genetics, Broad Institute, and Whitehead Institute for Biomedical Research, Cambridge, MA; Department of Genetics and Laboratory of Molecular Immunology, Harvard Medical School, Departments of Medicine and Molecular Biology, Massachusetts General Hospital, and Center for Neurologic Disease, Brigham and Women's Hospital, Boston; Georgetown University, Washington, DC; Department of Neurology, University of California at San Francisco, San Francisco; and Laboratory of Genomic Diversity, National Cancer Institute, and Basic Research Program, Science Applications International Corporation, Frederick, MD
| | - David Reich
- Program in Medical and Population Genetics, Broad Institute, and Whitehead Institute for Biomedical Research, Cambridge, MA; Department of Genetics and Laboratory of Molecular Immunology, Harvard Medical School, Departments of Medicine and Molecular Biology, Massachusetts General Hospital, and Center for Neurologic Disease, Brigham and Women's Hospital, Boston; Georgetown University, Washington, DC; Department of Neurology, University of California at San Francisco, San Francisco; and Laboratory of Genomic Diversity, National Cancer Institute, and Basic Research Program, Science Applications International Corporation, Frederick, MD
| |
Collapse
|
14
|
Bulik CM, Devlin B, Bacanu SA, Thornton L, Klump KL, Fichter MM, Halmi KA, Kaplan AS, Strober M, Woodside DB, Bergen AW, Ganjei JK, Crow S, Mitchell J, Rotondo A, Mauri M, Cassano G, Keel P, Berrettini WH, Kaye WH. Significant linkage on chromosome 10p in families with bulimia nervosa. Am J Hum Genet 2003; 72:200-7. [PMID: 12476400 PMCID: PMC378626 DOI: 10.1086/345801] [Citation(s) in RCA: 89] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2002] [Accepted: 10/22/2002] [Indexed: 01/17/2023] Open
Abstract
Bulimia nervosa (BN) is strongly familial, and additive genetic effects appear to contribute substantially to the observed familiality. In turn, behavioral components of BN, such as self-induced vomiting, are reliably measured and heritable. To identify regions of the genome harboring genetic variants conferring susceptibility to BN, we conducted a linkage analysis of multiplex families with eating disorders that were identified through a proband with BN. Linkage analysis of the entire sample of 308 families yielded a double peak, with the highest nonparametric multipoint maximum LOD score (MLS), of 2.92, on chromosome 10. Given the high heritability of self-induced vomiting and the reliability with which it can be measured, we performed linkage analysis in a subset (n=133) of families in which at least two affected relatives reported a symptom pattern that included self-induced vomiting. The highest MLS (3.39) observed was on chromosome 10, between markers D10S1430 and D10S1423. These results provide evidence of the presence of a susceptibility locus for BN on chromosome 10p. Using simulations, we demonstrate that both of these scores, 2.92 and 3.39, meet the widely accepted criterion for genomewide significance. Another region on 14q meets the criterion for genomewide suggestive linkage, with MLSs of 1.97 (full sample) and 1.75 (subset) at 62 centimorgans from p-ter.
Collapse
Affiliation(s)
- Cynthia M. Bulik
- Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond; Department of Psychiatry, University of Pittsburgh, Pittsburgh; Department of Psychology, Michigan State University, East Lansing; Roseneck Hospital for Behavioural Medicine affiliated with the University of Munich, Prien, Germany; New York Presbyterian Hospital, Weill Medical College of Cornell University, White Plains, NY; Program for Eating Disorders and Department of Psychiatry, University Health Network, Toronto General Hospital, Toronto; Department of Psychiatry and Behavioral Science, University of California at Los Angeles, Los Angeles; Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, and Biognosis, U.S., Gaithersburg, MD; Department of Psychiatry, University of Minnesota, Minneapolis; Neuropsychiatric Research Institute, Fargo, ND; Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Pisa, Italy; Department of Psychology, Harvard University, Cambridge; and Center of Neurobiology and Behavior, University of Pennsylvania, Philadelphia
| | - B. Devlin
- Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond; Department of Psychiatry, University of Pittsburgh, Pittsburgh; Department of Psychology, Michigan State University, East Lansing; Roseneck Hospital for Behavioural Medicine affiliated with the University of Munich, Prien, Germany; New York Presbyterian Hospital, Weill Medical College of Cornell University, White Plains, NY; Program for Eating Disorders and Department of Psychiatry, University Health Network, Toronto General Hospital, Toronto; Department of Psychiatry and Behavioral Science, University of California at Los Angeles, Los Angeles; Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, and Biognosis, U.S., Gaithersburg, MD; Department of Psychiatry, University of Minnesota, Minneapolis; Neuropsychiatric Research Institute, Fargo, ND; Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Pisa, Italy; Department of Psychology, Harvard University, Cambridge; and Center of Neurobiology and Behavior, University of Pennsylvania, Philadelphia
| | - Silviu-Alin Bacanu
- Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond; Department of Psychiatry, University of Pittsburgh, Pittsburgh; Department of Psychology, Michigan State University, East Lansing; Roseneck Hospital for Behavioural Medicine affiliated with the University of Munich, Prien, Germany; New York Presbyterian Hospital, Weill Medical College of Cornell University, White Plains, NY; Program for Eating Disorders and Department of Psychiatry, University Health Network, Toronto General Hospital, Toronto; Department of Psychiatry and Behavioral Science, University of California at Los Angeles, Los Angeles; Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, and Biognosis, U.S., Gaithersburg, MD; Department of Psychiatry, University of Minnesota, Minneapolis; Neuropsychiatric Research Institute, Fargo, ND; Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Pisa, Italy; Department of Psychology, Harvard University, Cambridge; and Center of Neurobiology and Behavior, University of Pennsylvania, Philadelphia
| | - Laura Thornton
- Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond; Department of Psychiatry, University of Pittsburgh, Pittsburgh; Department of Psychology, Michigan State University, East Lansing; Roseneck Hospital for Behavioural Medicine affiliated with the University of Munich, Prien, Germany; New York Presbyterian Hospital, Weill Medical College of Cornell University, White Plains, NY; Program for Eating Disorders and Department of Psychiatry, University Health Network, Toronto General Hospital, Toronto; Department of Psychiatry and Behavioral Science, University of California at Los Angeles, Los Angeles; Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, and Biognosis, U.S., Gaithersburg, MD; Department of Psychiatry, University of Minnesota, Minneapolis; Neuropsychiatric Research Institute, Fargo, ND; Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Pisa, Italy; Department of Psychology, Harvard University, Cambridge; and Center of Neurobiology and Behavior, University of Pennsylvania, Philadelphia
| | - Kelly L. Klump
- Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond; Department of Psychiatry, University of Pittsburgh, Pittsburgh; Department of Psychology, Michigan State University, East Lansing; Roseneck Hospital for Behavioural Medicine affiliated with the University of Munich, Prien, Germany; New York Presbyterian Hospital, Weill Medical College of Cornell University, White Plains, NY; Program for Eating Disorders and Department of Psychiatry, University Health Network, Toronto General Hospital, Toronto; Department of Psychiatry and Behavioral Science, University of California at Los Angeles, Los Angeles; Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, and Biognosis, U.S., Gaithersburg, MD; Department of Psychiatry, University of Minnesota, Minneapolis; Neuropsychiatric Research Institute, Fargo, ND; Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Pisa, Italy; Department of Psychology, Harvard University, Cambridge; and Center of Neurobiology and Behavior, University of Pennsylvania, Philadelphia
| | - Manfred M. Fichter
- Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond; Department of Psychiatry, University of Pittsburgh, Pittsburgh; Department of Psychology, Michigan State University, East Lansing; Roseneck Hospital for Behavioural Medicine affiliated with the University of Munich, Prien, Germany; New York Presbyterian Hospital, Weill Medical College of Cornell University, White Plains, NY; Program for Eating Disorders and Department of Psychiatry, University Health Network, Toronto General Hospital, Toronto; Department of Psychiatry and Behavioral Science, University of California at Los Angeles, Los Angeles; Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, and Biognosis, U.S., Gaithersburg, MD; Department of Psychiatry, University of Minnesota, Minneapolis; Neuropsychiatric Research Institute, Fargo, ND; Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Pisa, Italy; Department of Psychology, Harvard University, Cambridge; and Center of Neurobiology and Behavior, University of Pennsylvania, Philadelphia
| | - Katherine A. Halmi
- Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond; Department of Psychiatry, University of Pittsburgh, Pittsburgh; Department of Psychology, Michigan State University, East Lansing; Roseneck Hospital for Behavioural Medicine affiliated with the University of Munich, Prien, Germany; New York Presbyterian Hospital, Weill Medical College of Cornell University, White Plains, NY; Program for Eating Disorders and Department of Psychiatry, University Health Network, Toronto General Hospital, Toronto; Department of Psychiatry and Behavioral Science, University of California at Los Angeles, Los Angeles; Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, and Biognosis, U.S., Gaithersburg, MD; Department of Psychiatry, University of Minnesota, Minneapolis; Neuropsychiatric Research Institute, Fargo, ND; Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Pisa, Italy; Department of Psychology, Harvard University, Cambridge; and Center of Neurobiology and Behavior, University of Pennsylvania, Philadelphia
| | - Allan S. Kaplan
- Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond; Department of Psychiatry, University of Pittsburgh, Pittsburgh; Department of Psychology, Michigan State University, East Lansing; Roseneck Hospital for Behavioural Medicine affiliated with the University of Munich, Prien, Germany; New York Presbyterian Hospital, Weill Medical College of Cornell University, White Plains, NY; Program for Eating Disorders and Department of Psychiatry, University Health Network, Toronto General Hospital, Toronto; Department of Psychiatry and Behavioral Science, University of California at Los Angeles, Los Angeles; Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, and Biognosis, U.S., Gaithersburg, MD; Department of Psychiatry, University of Minnesota, Minneapolis; Neuropsychiatric Research Institute, Fargo, ND; Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Pisa, Italy; Department of Psychology, Harvard University, Cambridge; and Center of Neurobiology and Behavior, University of Pennsylvania, Philadelphia
| | - Michael Strober
- Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond; Department of Psychiatry, University of Pittsburgh, Pittsburgh; Department of Psychology, Michigan State University, East Lansing; Roseneck Hospital for Behavioural Medicine affiliated with the University of Munich, Prien, Germany; New York Presbyterian Hospital, Weill Medical College of Cornell University, White Plains, NY; Program for Eating Disorders and Department of Psychiatry, University Health Network, Toronto General Hospital, Toronto; Department of Psychiatry and Behavioral Science, University of California at Los Angeles, Los Angeles; Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, and Biognosis, U.S., Gaithersburg, MD; Department of Psychiatry, University of Minnesota, Minneapolis; Neuropsychiatric Research Institute, Fargo, ND; Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Pisa, Italy; Department of Psychology, Harvard University, Cambridge; and Center of Neurobiology and Behavior, University of Pennsylvania, Philadelphia
| | - D. Blake Woodside
- Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond; Department of Psychiatry, University of Pittsburgh, Pittsburgh; Department of Psychology, Michigan State University, East Lansing; Roseneck Hospital for Behavioural Medicine affiliated with the University of Munich, Prien, Germany; New York Presbyterian Hospital, Weill Medical College of Cornell University, White Plains, NY; Program for Eating Disorders and Department of Psychiatry, University Health Network, Toronto General Hospital, Toronto; Department of Psychiatry and Behavioral Science, University of California at Los Angeles, Los Angeles; Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, and Biognosis, U.S., Gaithersburg, MD; Department of Psychiatry, University of Minnesota, Minneapolis; Neuropsychiatric Research Institute, Fargo, ND; Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Pisa, Italy; Department of Psychology, Harvard University, Cambridge; and Center of Neurobiology and Behavior, University of Pennsylvania, Philadelphia
| | - Andrew W. Bergen
- Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond; Department of Psychiatry, University of Pittsburgh, Pittsburgh; Department of Psychology, Michigan State University, East Lansing; Roseneck Hospital for Behavioural Medicine affiliated with the University of Munich, Prien, Germany; New York Presbyterian Hospital, Weill Medical College of Cornell University, White Plains, NY; Program for Eating Disorders and Department of Psychiatry, University Health Network, Toronto General Hospital, Toronto; Department of Psychiatry and Behavioral Science, University of California at Los Angeles, Los Angeles; Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, and Biognosis, U.S., Gaithersburg, MD; Department of Psychiatry, University of Minnesota, Minneapolis; Neuropsychiatric Research Institute, Fargo, ND; Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Pisa, Italy; Department of Psychology, Harvard University, Cambridge; and Center of Neurobiology and Behavior, University of Pennsylvania, Philadelphia
| | - J. Kelly Ganjei
- Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond; Department of Psychiatry, University of Pittsburgh, Pittsburgh; Department of Psychology, Michigan State University, East Lansing; Roseneck Hospital for Behavioural Medicine affiliated with the University of Munich, Prien, Germany; New York Presbyterian Hospital, Weill Medical College of Cornell University, White Plains, NY; Program for Eating Disorders and Department of Psychiatry, University Health Network, Toronto General Hospital, Toronto; Department of Psychiatry and Behavioral Science, University of California at Los Angeles, Los Angeles; Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, and Biognosis, U.S., Gaithersburg, MD; Department of Psychiatry, University of Minnesota, Minneapolis; Neuropsychiatric Research Institute, Fargo, ND; Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Pisa, Italy; Department of Psychology, Harvard University, Cambridge; and Center of Neurobiology and Behavior, University of Pennsylvania, Philadelphia
| | - Scott Crow
- Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond; Department of Psychiatry, University of Pittsburgh, Pittsburgh; Department of Psychology, Michigan State University, East Lansing; Roseneck Hospital for Behavioural Medicine affiliated with the University of Munich, Prien, Germany; New York Presbyterian Hospital, Weill Medical College of Cornell University, White Plains, NY; Program for Eating Disorders and Department of Psychiatry, University Health Network, Toronto General Hospital, Toronto; Department of Psychiatry and Behavioral Science, University of California at Los Angeles, Los Angeles; Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, and Biognosis, U.S., Gaithersburg, MD; Department of Psychiatry, University of Minnesota, Minneapolis; Neuropsychiatric Research Institute, Fargo, ND; Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Pisa, Italy; Department of Psychology, Harvard University, Cambridge; and Center of Neurobiology and Behavior, University of Pennsylvania, Philadelphia
| | - James Mitchell
- Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond; Department of Psychiatry, University of Pittsburgh, Pittsburgh; Department of Psychology, Michigan State University, East Lansing; Roseneck Hospital for Behavioural Medicine affiliated with the University of Munich, Prien, Germany; New York Presbyterian Hospital, Weill Medical College of Cornell University, White Plains, NY; Program for Eating Disorders and Department of Psychiatry, University Health Network, Toronto General Hospital, Toronto; Department of Psychiatry and Behavioral Science, University of California at Los Angeles, Los Angeles; Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, and Biognosis, U.S., Gaithersburg, MD; Department of Psychiatry, University of Minnesota, Minneapolis; Neuropsychiatric Research Institute, Fargo, ND; Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Pisa, Italy; Department of Psychology, Harvard University, Cambridge; and Center of Neurobiology and Behavior, University of Pennsylvania, Philadelphia
| | - Alessandro Rotondo
- Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond; Department of Psychiatry, University of Pittsburgh, Pittsburgh; Department of Psychology, Michigan State University, East Lansing; Roseneck Hospital for Behavioural Medicine affiliated with the University of Munich, Prien, Germany; New York Presbyterian Hospital, Weill Medical College of Cornell University, White Plains, NY; Program for Eating Disorders and Department of Psychiatry, University Health Network, Toronto General Hospital, Toronto; Department of Psychiatry and Behavioral Science, University of California at Los Angeles, Los Angeles; Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, and Biognosis, U.S., Gaithersburg, MD; Department of Psychiatry, University of Minnesota, Minneapolis; Neuropsychiatric Research Institute, Fargo, ND; Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Pisa, Italy; Department of Psychology, Harvard University, Cambridge; and Center of Neurobiology and Behavior, University of Pennsylvania, Philadelphia
| | - Mauro Mauri
- Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond; Department of Psychiatry, University of Pittsburgh, Pittsburgh; Department of Psychology, Michigan State University, East Lansing; Roseneck Hospital for Behavioural Medicine affiliated with the University of Munich, Prien, Germany; New York Presbyterian Hospital, Weill Medical College of Cornell University, White Plains, NY; Program for Eating Disorders and Department of Psychiatry, University Health Network, Toronto General Hospital, Toronto; Department of Psychiatry and Behavioral Science, University of California at Los Angeles, Los Angeles; Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, and Biognosis, U.S., Gaithersburg, MD; Department of Psychiatry, University of Minnesota, Minneapolis; Neuropsychiatric Research Institute, Fargo, ND; Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Pisa, Italy; Department of Psychology, Harvard University, Cambridge; and Center of Neurobiology and Behavior, University of Pennsylvania, Philadelphia
| | - Giovanni Cassano
- Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond; Department of Psychiatry, University of Pittsburgh, Pittsburgh; Department of Psychology, Michigan State University, East Lansing; Roseneck Hospital for Behavioural Medicine affiliated with the University of Munich, Prien, Germany; New York Presbyterian Hospital, Weill Medical College of Cornell University, White Plains, NY; Program for Eating Disorders and Department of Psychiatry, University Health Network, Toronto General Hospital, Toronto; Department of Psychiatry and Behavioral Science, University of California at Los Angeles, Los Angeles; Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, and Biognosis, U.S., Gaithersburg, MD; Department of Psychiatry, University of Minnesota, Minneapolis; Neuropsychiatric Research Institute, Fargo, ND; Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Pisa, Italy; Department of Psychology, Harvard University, Cambridge; and Center of Neurobiology and Behavior, University of Pennsylvania, Philadelphia
| | - Pamela Keel
- Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond; Department of Psychiatry, University of Pittsburgh, Pittsburgh; Department of Psychology, Michigan State University, East Lansing; Roseneck Hospital for Behavioural Medicine affiliated with the University of Munich, Prien, Germany; New York Presbyterian Hospital, Weill Medical College of Cornell University, White Plains, NY; Program for Eating Disorders and Department of Psychiatry, University Health Network, Toronto General Hospital, Toronto; Department of Psychiatry and Behavioral Science, University of California at Los Angeles, Los Angeles; Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, and Biognosis, U.S., Gaithersburg, MD; Department of Psychiatry, University of Minnesota, Minneapolis; Neuropsychiatric Research Institute, Fargo, ND; Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Pisa, Italy; Department of Psychology, Harvard University, Cambridge; and Center of Neurobiology and Behavior, University of Pennsylvania, Philadelphia
| | - Wade H. Berrettini
- Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond; Department of Psychiatry, University of Pittsburgh, Pittsburgh; Department of Psychology, Michigan State University, East Lansing; Roseneck Hospital for Behavioural Medicine affiliated with the University of Munich, Prien, Germany; New York Presbyterian Hospital, Weill Medical College of Cornell University, White Plains, NY; Program for Eating Disorders and Department of Psychiatry, University Health Network, Toronto General Hospital, Toronto; Department of Psychiatry and Behavioral Science, University of California at Los Angeles, Los Angeles; Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, and Biognosis, U.S., Gaithersburg, MD; Department of Psychiatry, University of Minnesota, Minneapolis; Neuropsychiatric Research Institute, Fargo, ND; Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Pisa, Italy; Department of Psychology, Harvard University, Cambridge; and Center of Neurobiology and Behavior, University of Pennsylvania, Philadelphia
| | - Walter H. Kaye
- Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond; Department of Psychiatry, University of Pittsburgh, Pittsburgh; Department of Psychology, Michigan State University, East Lansing; Roseneck Hospital for Behavioural Medicine affiliated with the University of Munich, Prien, Germany; New York Presbyterian Hospital, Weill Medical College of Cornell University, White Plains, NY; Program for Eating Disorders and Department of Psychiatry, University Health Network, Toronto General Hospital, Toronto; Department of Psychiatry and Behavioral Science, University of California at Los Angeles, Los Angeles; Core Genotyping Facility, Advanced Technology Center, National Cancer Institute, and Biognosis, U.S., Gaithersburg, MD; Department of Psychiatry, University of Minnesota, Minneapolis; Neuropsychiatric Research Institute, Fargo, ND; Department of Psychiatry, Neurobiology, Pharmacology and Biotechnologies, University of Pisa, Pisa, Italy; Department of Psychology, Harvard University, Cambridge; and Center of Neurobiology and Behavior, University of Pennsylvania, Philadelphia
| |
Collapse
|